Cancer Causes and Prevention
Covers known cancer risk factors, how certain cancers can be prevented, and ongoing research into causes and prevention.
Covers known cancer risk factors, how certain cancers can be prevented, and ongoing research into causes and prevention.
Following the consensus that the risk-benefit assessments for the proposed indications for cilta-cel and ide-cel were favorable during the March 15, 2024, FDA ODAC meeting,…
Over the last ten years, Clinical Trials Day has celebrated achievements from the clinical research community and has shed light on the importance…
The European Society for Medical Oncology (ESMO) Breast Cancer Conference will be held in Berlin, Germany on the 15-17 May. This annual meeting will deliver…
The International Journal of Cancer is a cancer journal from the Union for International Cancer Control covering experimental and clinical cancer research.
In case you missed it, below is your guide to the important regulatory approvals made by the FDA in April 2024.
Registration is now open
Jean L. Koff, MD, MS, highlights data for pirtobrutinib in pretreated CLL/SLL and how the agent altered later-line care for these patients.
Samilia Obeng-Gyasi, MD, MPH, expands on the impact of social determinants of health on breast cancer care.
R. Lor Randall, MD, FACS, detailed research into the relationship between guideline-concordant care and survival outcomes in patients with osteosarcoma in California.